Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
DERMA SCIENCES, INC. (DSCI)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Sep-30-16 | Jun-30-16 | Mar-31-16 | Dec-31-15 | Sep-30-15 | Jun-30-15 | Mar-31-15 | Dec-31-14 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 50.9% | 62.8% | 61.9% | 58.6% | 59.0% | 62.9% | 61.4% | 60.7% |
| Gross profit | 49.1% | 37.2% | 38.1% | 41.4% | 41.0% | 37.1% | 38.6% | 39.3% |
| Selling, general and administrative | 62.8% | 46.3% | 49.2% | -7.3% | 68.7% | 60.7% | 68.0% | 53.6% |
| Research and development | 0.3% | | | | 0.7% | 1.0% | 1.8% | 27.4% |
| EBITDA | -8.6% | -6.0% | -7.4% | 52.4% | -24.2% | -21.3% | -27.3% | -34.2% |
| Depreciation | | | | | | | | 3.8% |
| EBITA | -8.6% | -6.0% | -7.4% | 52.4% | -24.2% | -21.3% | -27.3% | -38.0% |
| Amortization of intangibles | 5.4% | 3.2% | 3.7% | 3.7% | 4.2% | 3.3% | 3.8% | 3.7% |
| EBIT | -14.1% | -9.1% | -11.1% | 48.7% | -28.4% | -24.7% | -31.2% | -41.7% |
| Pre-tax income | -27.6% | 11.3% | -9.8% | 34.2% | -32.2% | -20.8% | -33.0% | -41.4% |
| Income taxes | -6.7% | 2.4% | -1.1% | -7.8% | -5.9% | 1.5% | 0.0% | 0.5% |
| Net income | -6.4% | 8.9% | -8.7% | -45.7% | -50.4% | -41.2% | -54.4% | -41.8% |
|